Natural progression of atherosclerosis from pathologic intimal thickening to late fibroatheroma in human coronary arteries: A pathology study

Atherosclerosis

Volumn 241, Issue 2, 2015, Pages 772-782

  Otsuka, Fumiyuki ^a   Kramer, Miranda C A ^b   Woudstra, Pier ^b   Yahagi, Kazuyuki ^a   Ladich, Elena ^a   Finn, Aloke V ^c   de Winter, Robbert J ^b   Kolodgie, Frank D ^a   Wight, Thomas N ^d   Davis, Harry R ^a   Joner, Michael ^a   Virmani, Renu ^a  

^a CVPATH INSTITUTE   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; Atherosclerosis; Calcification; Extracellular matrix; Macrophage; Pathology; Proteoglycans

Indexed keywords

ALIZARIN RED S; BIGLYCAN; DECORIN; HYALURONIC ACID; VERSICAN; LIPID; PROTEOGLYCAN;

ADULT; APOPTOSIS; ARTERY CALCIFICATION; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; CORONARY ARTERY; DISEASE COURSE; FEMALE; FIBROATHEROMA; HUMAN; HUMAN TISSUE; INFLAMMATION; LIPID STORAGE; MACROPHAGE; MALE; MIDDLE AGED; PATHOLOGY; PRIORITY JOURNAL; VASA VASORUM; BLOOD; CALCINOSIS; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; INTIMA; METABOLISM; PREVALENCE; RETROSPECTIVE STUDY;

ADULT; APOPTOSIS; ATHEROSCLEROSIS; CALCINOSIS; CORONARY ARTERY DISEASE; CORONARY VESSELS; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIPIDS; MACROPHAGES; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PREVALENCE; PROTEOGLYCANS; RETROSPECTIVE STUDIES; TUNICA INTIMA;

EID: 84955379843     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.05.011     Document Type: Article

References (49)

1. Nakashima Y., Wight T.N., Sueishi K. Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans. Cardiovasc. Res. 2008, 79:14-23.
2. Velican C., Velican D. Discrepancies between data on atherosclerotic involvement of human coronary arteries furnished by gross inspection and by light microscopy. Atherosclerosis 1982, 43:39-49.
3. McGill H.C., McMahan C.A., Herderick E.E., et al. Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery. PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler. Thromb. Vasc. Biol. 2000, 20:836-845.
4. Motoyama S., Sarai M., Harigaya H., et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J. Am. Coll. Cardiol. 2009, 54:49-57.
5. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005, 352:1685-1695.
6. Kockx M.M., Herman A.G. Apoptosis in atherosclerosis: beneficial or detrimental?. Cardiovasc. Res. 2000, 45:736-746.
7. Littlewood T.D., Bennett M.R. Apoptotic cell death in atherosclerosis. Curr. Opin. Lipidol. 2003, 14:469-475.
8. Schrijvers D.M., De Meyer G.R., Herman A.G., et al. Phagocytosis in atherosclerosis: molecular mechanisms and implications for plaque progression and stability. Cardiovasc. Res. 2007, 73:470-480.
9. Wight T.N. The vascular extracellular matrix. Chapter 24 Atherosclerosis and Coronary Artery Disease 1996, 421-440. Lippincott-Raven Publishers, Philadelphia, PA. V. Fuster, R. Ross, E.J. Topol (Eds.).
10. Wight T.N., Merrilees M.J. Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ. Res. 2004, 94:1158-1167.
11. Wight T.N. Arterial remodeling in vascular disease: a key role for hyaluronan and versican. Front. Biosci. 2008, 13:4933-4937.
12. Williams K.J., Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 1995, 15:551-561.
13. Kolodgie F.D., Burke A.P., Wight T.N., et al. The accumulation of specific types of proteoglycans in eroded plaques: a role in coronary thrombosis in the absence of rupture. Curr. Opin. Lipidol. 2004, 15:575-582.
14. Gustafsson M., Boren J. Mechanism of lipoprotein retention by the extracellular matrix. Curr. Opin. Lipidol. 2004, 15:505-514.
15. Nakashima Y., Fujii H., Sumiyoshi S., et al. Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1159-1165.
16. Kolodgie F.D., Burke A.P., Farb A., et al. Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1642-1648.
17. Virmani R., Kolodgie F.D., Burke A.P., et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1262-1275.
18. Kolodgie F.D., Gold H.K., Burke A.P., et al. Intraplaque hemorrhage and progression of coronary atheroma. N. Engl. J. Med. 2003, 349:2316-2325.
19. Kolodgie F.D., Narula J., Burke A.P., et al. Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am. J. Pathol. 2000, 157:1259-1268.
20. Evanko S.P., Raines E.W., Ross R., et al. Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta. Am. J. Pathol. 1998, 152:533-546.
21. Proudfoot D., Skepper J.N., Hegyi L., et al. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ. Res. 2000, 87:1055-1062.
22. Katz S.S., Shipley G.G., Small D.M. Physical chemistry of the lipids of human atherosclerotic lesions. Demonstration of a lesion intermediate between fatty streaks and advanced plaques. J. Clin. Invest. 1976, 58:200-211.
23. Felton C.V., Crook D., Davies M.J., et al. Relation of plaque lipid composition and morphology to the stability of human aortic plaques. Arterioscler. Thromb. Vasc. Biol. 1997, 17:1337-1345.
24. Gautier E.L., Huby T., Witztum J.L., et al. Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage. Circulation 2009, 119:1795-1804.
25. Schrijvers D.M., De Meyer G.R., Kockx M.M., et al. Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1256-1261.
26. Stoneman V.E., Bennett M.R. Role of apoptosis in atherosclerosis and its therapeutic implications. Clin. Sci. (Lond.) 2004, 107:343-354.
27. Fadok V.A., Bratton D.L., Konowal A., et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 1998, 101:890-898.
28. Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2255-2264.
29. Sambrano G.R., Steinberg D. Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc. Natl. Acad. Sci. USA 1995, 92:1396-1400.
30. Chang M.K., Bergmark C., Laurila A., et al. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc. Natl. Acad. Sci. USA 1999, 96:6353-6358.
31. Merrilees M.J., Beaumont B., Scott L.J. Comparison of deposits of versican, biglycan and decorin in saphenous vein and internal thoracic, radial and coronary arteries: correlation to patency. Coron. Artery Dis. 2001, 12:7-16.
32. Radhakrishnamurthy B., Jeansonne N., Tracy R.E., et al. A monoclonal antibody that recognizes hyaluronic acid binding region of aorta proteoglycans. Atherosclerosis 1993, 98:179-192.
33. Levesque H., Girard N., Maingonnat C., et al. Localization and solubilization of hyaluronan and of the hyaluronan-binding protein hyaluronectin in human normal and arteriosclerotic arterial walls. Atherosclerosis 1994, 105:51-62.
34. Binette F., Cravens J., Kahoussi B., et al. Link protein is ubiquitously expressed in non-cartilaginous tissues where it enhances and stabilizes the interaction of proteoglycans with hyaluronic acid. J. Biol. Chem. 1994, 269:19116-19122.
35. Halpert I., Sires U.I., Roby J.D., et al. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc. Natl. Acad. Sci. USA 1996, 93:9748-9753.
36. Lin H., Wilson J.E., Roberts C.R., et al. Biglycan, decorin, and versican protein expression patterns in coronary arteriopathy of human cardiac allograft: distinctness as compared to native atherosclerosis. J. Heart Lung Transpl. 1996, 15:1233-1247.
37. Riessen R., Isner J.M., Blessing E., et al. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am. J. Pathol. 1994, 144:962-974.
38. Chait A., Wight T.N. Interaction of native and modified low-density lipoproteins with extracellular matrix. Curr. Opin. Lipidol. 2000, 11:457-463.
39. Kawashima H., Hirose M., Hirose J., et al. Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44. J. Biol. Chem. 2000, 275:35448-35456.
40. de la Motte C.A., Hascall V.C., Drazba J., et al. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am. J. Pathol. 2003, 163:121-133.
41. de La Motte C.A., Hascall V.C., Calabro A., et al. Mononuclear leukocytes preferentially bind via CD44 to hyaluronan on human intestinal mucosal smooth muscle cells after virus infection or treatment with poly(I.C). J. Biol. Chem. 1999, 274:30747-30755.
42. Hirose J., Kawashima H., Yoshie O., et al. Versican interacts with chemokines and modulates cellular responses. J. Biol. Chem. 2001, 276:5228-5234.
43. Nagy N., Freudenberger T., Melchior-Becker A., et al. Inhibition of hyaluronan synthesis accelerates murine atherosclerosis: novel insights into the role of hyaluronan synthesis. Circulation 2010, 122:2313-2322.
44. Edwards I.J., Wagner W.D., Owens R.T. Macrophage secretory products selectively stimulate dermatan sulfate proteoglycan production in cultured arterial smooth muscle cells. Am. J. Pathol. 1990, 136:609-621.
45. Ostberg C.O., Zhu P., Wight T.N., et al. Fibronectin attachment is permissive for IL-1 mediated gene regulation. FEBS Lett. 1995, 367:93-97.
46. Mjaatvedt C.H., Yamamura H., Capehart A.A., et al. The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev. Biol. 1998, 202:56-66.
47. Cheng C., Tempel D., van Haperen R., et al. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation 2006, 113:2744-2753.
48. Chen Y.C., Bui A.V., Diesch J., et al. A novel mouse model of atherosclerotic plaque instability for drug testing and mechanistic/therapeutic discoveries using gene and microRNA expression profiling. Circ. Res. 2013, 113:252-265.
49. Van der Donckt C., Van Herck J.L., Schrijvers D.M., et al. Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death. Eur. Heart J. 2015, 36:1049-1058.